# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Retroperitoneal fibrosis

Ormond's Disease
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 10 results.
Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis
Status: Recruiting
Last Changed: Aug 06, 2019
First Received: Aug 06, 2019
Disease(s): Retroperitoneal Fibrosis
Intervention(s): Sirolimus, Corticosteroid
Locations: Peking University International Hospital, Beijing, Beijing, China
Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis
Status: Unknown status
Last Changed: Feb 27, 2007
First Received: Feb 27, 2007
Disease(s): Retroperitoneal Fibrosis
Intervention(s): Tamoxifen, Prednisone
Locations: Department of Clinical Medicine Nephrology and Health Science, Parma University Hospital, Parma, Italy
National Registry of IRPF in China
Status: Recruiting
Last Changed: Mar 19, 2020
First Received: Mar 19, 2020
Disease(s): Idiopathic Retroperitoneal Fibrosis
Locations: Peking Union Medical College Hospital, Beijing, Beijing, China
A Prospective Cohort Study of IRPF in China
Status: Recruiting
Last Changed: Mar 18, 2020
First Received: Mar 18, 2020
Disease(s): Idiopathic Retroperitoneal Fibrosis
Locations: Peking Union Medical College Hospital, Beijing, Beijing, China
Aortitis and Retroperitoneal Fibrosis: Evaluation of Diagnostic Criteria
Status: Unknown status
Last Changed: Apr 28, 2017
First Received: Apr 28, 2017
Disease(s): Idiopathic Aortitis, Retroperitoneal Fibrosis
Intervention(s): Establish the clinical, biological and radiological characteristics of patients
Locations: CHU Amiens Picardie, Amiens, Picardie, France
Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial
Status: Unknown status
Last Changed: Nov 15, 2010
First Received: Nov 15, 2010
Disease(s): Idiopathic Retroperitoneal Fibrosis, Perianeurysmal Retroperitoneal Fibrosis, Chronic Periaortitis
Intervention(s): Methotrexate+Prednisone, Prednisone
Locations: Nephrology Unit, University Hospital of Parma, Parma, Italy
Rituximab in IgG4-RD: A Phase 1-2 Trial
Status: Completed
Last Changed: Jul 02, 2017
First Received: Apr 25, 2012
Disease(s): Retroperitoneal Fibrosis, Autoimmune Pancreatitis, Sialadenitis, Pseudotumor
Intervention(s): Rituximab
Atorvastatin as an Adjunct to DFDBA in Intrabony Defects
Status: Completed
Last Changed: Jan 04, 2017
First Received: Jan 04, 2017
Disease(s): Chronic Periaortitis, Intrabony Periodontal Defect
Intervention(s): DFDBA, DFDBA with atorvastatin
Treatment of IgG4-Related Disease With Revlimid and Rituximab
Status: Completed
Last Changed: Jul 08, 2019
First Received: Mar 10, 2016
Disease(s): Immunoglobulin G Subclass 4 Related Disease, IgG4-related Disease, Autoimmune Pancreatitis, IgG4-related Sclerosing Cholangitis, Retroperitoneal Fibrosis
Intervention(s): Rituximab, Lenalidomide
Locations: Mayo Clinic in Rochester, Rochester, Minnesota, United States
Leflunomide for Maintenance of Remission in IgG4 Related Disease
Status: Completed
Last Changed: Mar 06, 2019
First Received: Mar 09, 2016
Disease(s): Immunoglobulin G4 Related Sclerosing Disease
Intervention(s): Prednisone, Leflunomide
Locations: Chinese PLA General Hospital, Beijing, China